Our findings revealed that Skp2 is a prognostic marker that is frequently overexpressed in osteosarcoma, and that genetic knockdown of Skp2 effectively inhibits osteosarcoma invasion and metastasis. This evidence concerns the gene SKP2 and osteosarcoma.